Drug information
Audio
Symtuza.mp3 |
Brand Name
Symtuza
Other Names
DRV/COBI/FTC/TAF, darunavir ethanolate/cobicistat/emtricitabine/tenofovir AF, darunavir ethanolate/cobicistat/emtricitabine/tenofovir alafenamide, darunavir/cobicistat/emtricitabine/tenofovir AF, darunavir/cobicistat/emtricitabine/tenofovir alafenamide fumarate
Drug Class
Combination Drugs
Protease Inhibitor (darunavir)
Nucleoside Reverse Transcriptase Inhibitor (emtricitabine, tenofovir alafenamide)
Pharmacokinetic Enhancer (cobicistat)
darunavir ethanolate
Molecular Weight: 593.7377
cobicistat
Molecular Weight: 776.0347
emtricitabine
Molecular Weight: 247.249
tenofovir alafenamide fumarate
Molecular Weight: 1069.0138
(The drug image[s] shown above is of the brand product only. There may be other available products not shown.)
FDA label informationFDA label information
Several FDA-approved drug labels may be available for darunavir / cobicistat / emtricitabine / tenofovir alafenamide. Clinicalinfo provides the following link to the DailyMed drug label solely as an example of the labels available for darunavir / cobicistat / emtricitabine / tenofovir alafenamide. Inclusion or absence of a drug label link on the Clinicalinfo site does not imply endorsement or lack thereof by Clinicalinfo. Search DailyMed or Drugs@FDA to access more information on darunavir / cobicistat / emtricitabine / tenofovir alafenamide, including additional drug labels and any generic equivalents.